Cancer
Immunotherapy
Month

A Message from Our CEO

Welcome to Cancer Immunotherapy Month – a time to celebrate progress, recognize potential, and elevate the people powering the immunotherapy revolution in cancer treatment.

Get an inside look at what’s in store this June as CRI CEO Dr. Alicia Zhou kicks off Cancer Immunotherapy Month with a message of progress, purpose, and possibility.


CRI Names 25 New Postdoctoral Fellows, Fulfilling $2.5M Commitment Amid NIH Disruptions

This is the first class selected since CRI’s $2.5M emergency pledge to expand postdoctoral funding and extend support for current fellows—advancing research despite growing uncertainty in federal science funding.

Explore the History of Cancer Immunotherapy

CRI charts the 100+ year journey that transformed immunotherapy from a bold idea into one of the most powerful tools in cancer care. Explore the scientific breakthroughs, visionary researchers, and lifesaving treatments that redefined what’s possible—then and now.

Meet the 2025 Lloyd J. Old STARs

CRI proudly announces the 2025 class of Lloyd J. Old STARs—five rising scientific leaders poised to reshape cancer immunotherapy through daring, paradigm-shifting research. Each awardee receives $1.25 million in unrestricted funding over five years, empowering them to pursue high-risk, high-reward projects that could redefine cancer treatment.

How Immunotherapy Changed Everything

In this unfiltered discussion, survivors Karen Peterson, Tom Vibert, and Brendan Connors open up about navigating stage 4 diagnoses, accessing groundbreaking treatments, and finding strength through science, advocacy, and community. These stories reveal what’s possible when patients are empowered and research leads the way.

Hope in Action: A Patient’s Guide to Cancer Immunotherapy

Whether you’re a patient, caregiver, or loved one, this guide is a clear, compassionate resource for anyone impacted by cancer. Developed with input from survivors and medical experts, the guide is designed to help readers make informed decisions and feel less alone during their cancer journey.

Introducing CRI’s 2025 Cancer Immunotherapy Insights + Impact Report

Explore CRI’s first comprehensive, data-driven look at the trajectory of cancer immunotherapy, tracing the evolution of the field from 2011 through the end of 2024. 

Why We Give: Real Stories of Hope, Loss, and the Drive to a Future #Immune2Cancer

Read the personal stories behind CRI’s supporters and discover the hope, loss, and love that drive a shared vision for a world #Immune2Cancer.


Learn and Explore

Panel: How AI and Biology are Shaping Immunotherapy

5 Ways AI is Changing the Landscape of Cancer Research and Immunotherapy

Explore key insights from a recent discussion with scientists and biotech leaders on how AI is transforming cancer immunotherapy.

Immuno-Oncology Expert Panel Webinar

Immuno-Oncology 2025: Expert Panel Weighs in on AI, Cell Therapy and Clinical Breakthroughs 

Understand 8 key takeaways on the state of Immuno-Oncology from this webinar featuring expert panelists from MD Anderson Cancer Center, IO Biotech & more.

Immunotherapy vs. Chemotherapy: What’s the Difference?

Learn how cancer immunotherapy and chemotherapy differ in how they treat cancer, their side effects, and how each approach affects the immune system.

cancer types

5 Things to Know When Considering Immunotherapy

Five essential things to know before starting cancer immunotherapy, from how it works to who is a potential candidate to receive it.